Discontinuation of insulin detemir by all Sub-ICB Locations
Why it matters: Novo Nordisk are discontinuing all formulations of Levemir®, the only insulin detemir product available in the UK, with supply due to exhaust by December 2026.
The Primary Care Diabetes & Obesity Society (PCDOS) and Association of British Clinical Diabetologists (ABCD) have written guidance to support clinicians in selecting and safely initiating alternative basal insulins. The guidance recommends that local teams diversify prescribing across the available options to reduce supply risks. Given the significant regional variation in prescribing, it also advises using data to support planning.
This OpenPrescribing measure, alongside it’s OpenPrescribing Hospitals counterpart provides data on variation across primary and secondary care to support this planning.
Description: Insulin detemir items per 1000 patients
Explore:
Tagged as: Diabetes (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →
Fetching data...